Loading clinical trials...
Loading clinical trials...
This study is a randomized, double-Blind, placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Cli...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bambusa Therapeutics
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07509606 · Chronic Obstructive Pulmonary Disease (COPD), Whole Body Vibration
NCT07451977 · Chronic Respiratory Failure, Hypoxemia, and more
NCT07082738 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07477600 · Chronic Obstructive Pulmonary Disease (COPD)
The Second Hospital of Anhui Medical Univesity
Hefei, Anhui
The third affiliated hosptial of Guangzhou Medical University
Guangzhou, Guangdong
The First Affiliated Hospital of Guangdong Medical University
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions